Shusuke Yoshikawa

10PUBLICATIONS
39CO-AUTHORS
NanomedicinePredictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|May 05, 2026
Melanoma Dissemination Through Bullous Solar Elastosis: Previously Undescribed Pattern of Cancer Dissemination.

|Feb 13, 2026
Clinical Outcomes of Dacarbazine After Failure of Immune Checkpoint Inhibitors: A Case Study of 15 Japanese Patients With Malignant Melanoma.

Ken Horisaki, Shusuke Yoshikawa, Wataru Omata

|Jan 08, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|Jan 07, 2026
Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective Study.

Ken Horisaki, Shusuke Yoshikawa, Wataru Omata

|Oct 07, 2025
C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort Study.

Ken Horisaki, Shusuke Yoshikawa, Wataru Omata

Pageof 2

Frequent Collaborators

7 joint publications

Ken Horisaki

2 joint publications

Kenjiro Namikawa

2 joint publications

Shigeto Matsushita

2 joint publications

Takeo Maekawa